Literature DB >> 26408564

Bilateral Facial Palsy following Ipilimumab Infusion for Melanoma.

Ashley L Altman1, Justin S Golub2, Myles L Pensak1, Ravi N Samy3.   

Abstract

Entities:  

Keywords:  facial palsy; ipilimumab; neuropathy

Mesh：

Substances：

Year:  2015        PMID： 26408564     DOI： 10.1177/0194599815606701

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN： 0194-5998            Impact factor:   3.497


× No keyword cloud information.
  10 in total

Review 1.  Proposed diagnostic and treatment paradigm for high-grade neurological complications of immune checkpoint inhibitors.

Authors:  Dustin Anderson; Grayson Beecher; Nabeela Nathoo; Michael Smylie; Jennifer A McCombe; John Walker; Rajive Jassal
Journal:  Neurooncol Pract       Date:  2018-10-04

Review 2.  Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.

Authors:  Peter Chei-Way Pan; Aya Haggiagi
Journal:  Curr Oncol Rep       Date:  2019-11-27       Impact factor: 5.075

3.  Neurologic Toxicities of Immunotherapy.

Authors:  Rebecca A Harrison; Nazanin K Majd; Sudhakar Tummala; John F de Groot
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management.

Authors:  Christophoros Astaras; Rita de Micheli; Bianca Moura; Thomas Hundsberger; Andreas F Hottinger
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-01       Impact factor: 5.081

5.  Acute Inflammatory Demyelinating Polyneuroradiculopathy with Ipilimumab in Metastatic Melanoma: A Case Report and Review of Literature.

Authors:  Chintan Rupareliya; Syeda Naqvi; Vishal B Jani
Journal:  Cureus       Date:  2017-06-05

6.  An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients.

Authors:  Elizabeth Colston; Dennis Grasela; David Gardiner; R Pat Bucy; Blisse Vakkalagadda; Alan J Korman; Israel Lowy
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

Review 7.  Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2018-09-14       Impact factor: 6.570

Review 8.  [Clinical Diagnosis and Treatment Recommendations for Adverse Reaction in the Nervous System Related to Immunocheckpoint Inhibitor].

Authors:  Jiayu Shi; Jingwen Niu; Dongchao Shen; Yi Li; Mingsheng Liu; Ying Tan; Liying Cui; Yuzhou Guan; Li Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-10-20

9.  Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related adverse reactions in the nervous system.

Authors:  Jiayu Shi; Jingwen Niu; Dongchao Shen; Mingsheng Liu; Ying Tan; Yi Li; Yangyu Huang; Liying Cui; Yuzhou Guan; Li Zhang
Journal:  Thorac Cancer       Date:  2019-12-10       Impact factor: 3.500

Review 10.  Immune Checkpoint Inhibitors and Neurotoxicity.

Authors:  Zhiyi Zhao; Chunlin Zhang; Lian Zhou; Pan Dong; Lei Shi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.